Compare CMG & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMG | IQV |
|---|---|---|
| Founded | 1993 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.6B | 41.3B |
| IPO Year | 2006 | 2013 |
| Metric | CMG | IQV |
|---|---|---|
| Price | $40.57 | $238.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 27 | 15 |
| Target Price | $48.78 | ★ $242.60 |
| AVG Volume (30 Days) | ★ 14.7M | 1.0M |
| Earning Date | 02-03-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.56 | N/A |
| EPS | 1.13 | ★ 7.30 |
| Revenue | $11,787,400,000.00 | ★ $15,904,000,000.00 |
| Revenue This Year | $6.28 | $6.15 |
| Revenue Next Year | $9.85 | $5.36 |
| P/E Ratio | $35.90 | ★ $32.73 |
| Revenue Growth | ★ 7.31 | 3.85 |
| 52 Week Low | $29.75 | $134.65 |
| 52 Week High | $59.57 | $247.05 |
| Indicator | CMG | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 66.67 | 55.99 |
| Support Level | $38.91 | $230.65 |
| Resistance Level | $41.42 | $242.99 |
| Average True Range (ATR) | 1.20 | 5.83 |
| MACD | 0.01 | -0.53 |
| Stochastic Oscillator | 84.46 | 64.08 |
Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $11.3 billion in 2024. The Mexican food concept is almost exclusively company-owned, with just a handful of franchise stores operated through a master franchise relationship with Alshaya Group in the Middle East. It had close to 4,000 stores at the end of September 2025, heavily indexed to the United States, although it maintains a small presence in Canada, the UK, France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.